$33.95 Billion in Sales Expected for Walgreens Boots Alliance Inc (NASDAQ:WBA) This Quarter

Brokerages expect Walgreens Boots Alliance Inc (NASDAQ:WBA) to announce $33.95 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have made estimates for Walgreens Boots Alliance’s earnings, with the highest sales estimate coming in at $34.38 billion and the lowest estimate coming in at $33.16 billion. Walgreens Boots Alliance reported sales of $33.44 billion in the same quarter last year, which indicates a positive year over year growth rate of 1.5%. The company is expected to issue its next earnings report on Thursday, October 10th.

According to Zacks, analysts expect that Walgreens Boots Alliance will report full year sales of $136.98 billion for the current financial year, with estimates ranging from $136.07 billion to $137.58 billion. For the next year, analysts forecast that the business will report sales of $140.08 billion, with estimates ranging from $137.82 billion to $141.98 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that follow Walgreens Boots Alliance.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a net margin of 3.53% and a return on equity of 22.08%. The company had revenue of $34.59 billion for the quarter, compared to analyst estimates of $34.52 billion. During the same quarter in the previous year, the firm posted $1.53 earnings per share. The company’s quarterly revenue was up .7% compared to the same quarter last year.

A number of research firms recently weighed in on WBA. Pivotal Research decreased their target price on shares of Walgreens Boots Alliance from $70.00 to $60.00 and set a “hold” rating on the stock in a report on Wednesday, April 3rd. SunTrust Banks upped their target price on shares of Walgreens Boots Alliance to $58.00 and gave the stock a “hold” rating in a report on Wednesday, April 3rd. ValuEngine lowered shares of WideOpenWest from a “hold” rating to a “sell” rating in a report on Friday, June 28th. TheStreet lowered shares of 22nd Century Group from a “c-” rating to a “d+” rating in a report on Friday, March 29th. Finally, Mizuho set a $67.00 target price on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Thursday, March 28th. Six equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the stock. Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $63.82.

Walgreens Boots Alliance stock traded down $0.09 during midday trading on Thursday, reaching $55.49. 6,104,833 shares of the stock were exchanged, compared to its average volume of 6,279,469. The firm has a fifty day simple moving average of $52.74. The company has a current ratio of 0.76, a quick ratio of 0.37 and a debt-to-equity ratio of 0.49. The stock has a market cap of $50.61 billion, a price-to-earnings ratio of 9.22, a PEG ratio of 1.33 and a beta of 0.82. Walgreens Boots Alliance has a 52 week low of $49.31 and a 52 week high of $86.31.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Monday, May 20th were issued a $0.44 dividend. The ex-dividend date of this dividend was Friday, May 17th. This represents a $1.76 annualized dividend and a yield of 3.17%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.

In related news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $53.05, for a total value of $1,061,000.00. Following the completion of the transaction, the chief accounting officer now directly owns 435,811 shares in the company, valued at approximately $23,119,773.55. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 15.73% of the stock is currently owned by corporate insiders.

Several institutional investors have recently modified their holdings of WBA. LSV Asset Management grew its position in Walgreens Boots Alliance by 0.9% during the 1st quarter. LSV Asset Management now owns 11,672,531 shares of the pharmacy operator’s stock valued at $738,521,000 after purchasing an additional 107,600 shares during the last quarter. Northern Trust Corp grew its position in Walgreens Boots Alliance by 5.8% during the 4th quarter. Northern Trust Corp now owns 11,641,152 shares of the pharmacy operator’s stock valued at $795,439,000 after purchasing an additional 641,721 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 7.8% during the 4th quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock valued at $786,522,000 after acquiring an additional 834,241 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Walgreens Boots Alliance by 11.4% during the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 10,667,865 shares of the pharmacy operator’s stock valued at $674,956,000 after acquiring an additional 1,093,610 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at about $589,781,000. Institutional investors own 61.52% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: Purposes and Functions of the Federal Reserve

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit